@article{1ccda9e8b7934cfdbb2247def5c027d3,
title = "Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer",
abstract = "Adenoviruses are used extensively as gene transfer agents, both experimentally and clinically. However, targeting of liver cells by adenoviruses compromises their potential efficacy. In cell culture, the adenovirus serotype 5 fiber protein engages the coxsackievirus and adenovirus receptor (CAR) to bind cells. Paradoxically, following intravascular delivery, CAR is not used for liver transduction, implicating alternate pathways. Recently, we demonstrated that coagulation factor (F)X directly binds adenovirus leading to liver infection. Here, we show that FX binds to the Ad5 hexon, not fiber, via an interaction between the FX Gla domain and hypervariable regions of the hexon surface. Binding occurs in multiple human adenovirus serotypes. Liver infection by the FX-Ad5 complex is mediated through a heparin-binding exosite in the FX serine protease domain. This study reveals an unanticipated function for hexon in mediating liver gene transfer in vivo.",
keywords = "HUMDISEASE, MICROBIO",
author = "Waddington, {Simon N.} and McVey, {John H.} and David Bhella and Parker, {Alan L.} and Kristeen Barker and Hideko Atoda and Rebecca Pink and Buckley, {Suzanne M.K.} and Greig, {Jenny A.} and Laura Denby and Jerome Custers and Takashi Morita and Francischetti, {Ivo M.B.} and Monteiro, {Robson Q.} and Barouch, {Dan H.} and {van Rooijen}, Nico and Claudio Napoli and Havenga, {Menzo J.E.} and Nicklin, {Stuart A.} and Baker, {Andrew H.}",
note = "Funding Information: We thank Erguang Li for the plasmids to make Ad5-21R and Ad5-7.5R, Linda Klavinskis for CD46 transgenic mice, and Dan Johnson for the EGF2-SP FX. We thank Professor Charles Coutelle for helpful discussions. We thank Nicola Britton and Gregor Aitchison for technical support and Lennart Holterman for virus production. Gary Childs and staff provided valuable technical support for in vivo studies. Professor Gadi Frankel and Siouxsie Wiles (Imperial College London) provided training and access to the Xenogen equipment. This work was supported by the European Commission, the Biotechnology and Biophysical Research Council, and British Heart Foundation. Haemostasis and Thrombosis are supported by the Medical Research Council. A.L.P. is funded by a Personal Research Fellowship from the Caledonian Research Foundation. S.W. is a recipient of the Philip Gray Fellowship, Katharine Dormandy Trust. ",
year = "2008",
month = feb,
day = "8",
doi = "10.1016/j.cell.2008.01.016",
language = "English (US)",
volume = "132",
pages = "397--409",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "3",
}